ASP Isotopes (ASPI) Research & Development (2022 - 2026)

ASP Isotopes' Research & Development history runs 5 years deep, the most recent figure standing at $5.3 million for Q1 2026.

• On a quarterly basis, Research & Development rose 243.99% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $16.1 million, a 261.29% increase from a year earlier, with the FY2025 full-year figure at $12.4 million, up 293.69% from the prior year.
• Research & Development eased to $5.3 million in Q1 2026 per ASPI's latest filing, from $6.8 million in the prior quarter.
• Across five years, Research & Development topped out at $6.8 million in Q4 2025 and bottomed at $65168.0 in Q4 2023.
• The 5-year median for Research & Development is $473302.0 (2024), against an average of $1.3 million.
• Across the five-year window, Research & Development slumped 67.91% in 2023 and surged 2073.03% in 2024, its largest moves.
• Year by year, Research & Development stood at $81635.0 in 2022, then decreased by 20.17% to $65168.0 in 2023, then jumped by 2073.03% to $1.4 million in 2024, then surged by 383.7% to $6.8 million in 2025, then declined by 23.17% to $5.3 million in 2026.
• Per Business Quant, the three latest ASPI Research & Development figures stand at $5.3 million (Q1 2026), $6.8 million (Q4 2025), and $3.1 million (Q3 2025).